Abstract:In this initial series of patients undergoing thoracic aortic surgery, tranexamic acid appeared effective in reducing perioperative bleeding, with a significant reduction in the need for allogeneic transfusions and without any increased risk of thrombotic complications.
“…Earlier studies have confirmed the favorable effects of antifibrinolytics, including tranexamic acid, on bleeding tendency in patients undergoing cardiac, major orthopedic, transplantation, and prostate surgeries [5,6]. Of particular interest is the increasing use of tranexamic acid by oral surgeons in the form of mouthwash for dental extractions [7,8] and in the management of epistaxis with hereditary hemorrhagic telangiectasia [9,10].…”
“…Earlier studies have confirmed the favorable effects of antifibrinolytics, including tranexamic acid, on bleeding tendency in patients undergoing cardiac, major orthopedic, transplantation, and prostate surgeries [5,6]. Of particular interest is the increasing use of tranexamic acid by oral surgeons in the form of mouthwash for dental extractions [7,8] and in the management of epistaxis with hereditary hemorrhagic telangiectasia [9,10].…”
“…Although the usefulness of tranexamic acid for DIC caused by aortic dissection has been reported as an alternative treatment to surgical repair (4, 5) and for preoperative control of bleeding complications (8), few articles have discussed the long-term safety and outcomes with this regimen. Therefore, we believe this report will help further clarify potential treatments for this uncommon disorder.…”
The management of chronic disseminated intravascular coagulation (DIC) caused by aortic dissection has not yet been established. Even in cases where surgical correction is performed, therapeutic control of systemic hemorrhaging is still required. We herein report the successful treatment of a case of aortic dissection with a patent false lumen using tranexamic acid for acute exacerbation of chronic DIC. Oral administration of 1,500 mg tranexamic acid per day stabilized the coagulative and fibrinolytic parameters and relieved bleeding tendencies with no side effects. Heparin was administered periodically for the management of hemodialysis. This favorable result continued for up to 3 years.
“…26 -32 Although the incidence is low, 27-32 a dreadful side effect of this drug is increased risk of thromboembolic effects such as acute myocardial infarction, cerebral embolism, pulmonary embolism, and renal pelvis emboli. 26,27 The dose and duration that were used in this study were lower than those reported in the aforementioned studies. 26 -32 Perhaps because of dietary and genetic difference, incidence of postoperative thromboembolism after major surgery tends to be lower among Eastern Asians than among whites.…”
Perioperative parenteral use of TA reduced the amount of operative blood loss and the need for blood transfusion in elective liver tumor resection. A real "blood transfusion"-free hepatectomy may be feasible with the assistance of parenteral TA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.